Our Mission
Committed to significantly moving patient care forward by supporting development of commercially viable therapeutics and diagnostics. Providing all the resources necessary in-house to identify major unmet medical needs and drive impactful solutions for patients.
Venture studio focused on building companies from the ground up around innovative technologies.
Our Latest News

AUSTIN, Texas and HAMILTON, ON and SOUTH SAN FRANCISCO, Calif., Jan. 5, 2023 /PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells…

Seeds from Mayo Clinic’s cell and gene therapy accelerator Mayflower Bioventures have taken flight in a new biotech called Primera Therapeutics, which launches today with a blossoming $750 million partnership…